经导管主动脉瓣置换术后瓣膜长期耐久性:5至10年随访结果
本研究基于英国TAVI注册研究,纳入241例有基线和≥5年超声心动图数据的TAVR患者,评估术后5至10年结构性瓣膜退化(SVD)的发生率。结果显示长期瓣膜功能良好,91%的患者在5至10年间无SVD,重度SVD发生率<1%,中度SVD发生于约1/12的患者。
要点
- TAVR术后5至10年,91%的患者无结构性瓣膜退化。
- 重度SVD发生率<1%,仅1例(0.4%)在5.3年出现新发重度反流。
- 中度SVD发生率为8.7%(21例),平均6.1年,其中57%为新发反流,43%为再狭窄。
核心结论
- 经导管主动脉瓣长期功能优秀,5至10年随访期间91%的患者无SVD,重度SVD发生率<1%。
研究设计与样本
- 回顾性队列研究,数据来自英国TAVI注册研究,纳入2007至2011年接受TAVR且有基线和≥5年超声心动图数据的241例患者(年龄79.3±7.5岁,46%女性)。
主要发现
- 随访中位5.8年(范围5至10年),随访时峰值主动脉瓣压差低于术后(17.1 vs. 19.1 mm Hg;p=0.002)。
- 随访时无/微量主动脉瓣反流(AR)的患者比例高于术后(47.5% vs. 33%),轻度AR比例更低(42.5% vs. 57%)(p=0.02)。
- 重度SVD 1例(0.4%),发生于植入后5.3年,表现为新发重度AR。
- 中度SVD 21例(8.7%),平均发生于植入后6.1年(范围4.9至8.6年),其中12例(57%)因新发AR,9例(43%)因再狭窄。
临床怎么用
- TAVR术后5至10年瓣膜耐久性良好,支持TAVR在适合患者中的长期应用。
- 术后长期随访中需关注SVD,尤其是新发主动脉瓣反流和再狭窄。
局限性
- 仅纳入有配对超声心动图数据的患者,可能存在选择偏倚。
- 样本量较小(241例),且来自单国注册研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Very little is known about long-term valve durability after transcatheter aortic valve replacement (TAVR). OBJECTIVES: This study sought to evaluate the incidence of structural valve degeneration (SVD) 5 to 10 years post-procedure. METHODS: Demographic, procedural, and in-hospital outcome data on patients who underwent TAVR from 2007 to 2011 were obtained from the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. Patients in whom echocardiographic data were available both at baseline and ≥5 years post-TAVR were included. Hemodynamic SVD was determined according to European task force committee guidelines. RESULTS: A total of 241 patients (79.3 ± 7.5 years of age; 46% female) with paired post-procedure and late echocardiographic follow-up (median 5.8 years, range 5 to 10 years) were included. A total of 149 patients (64%) were treated with a self-expandable valve and 80 (34.7%) with a balloon-expandable valve. Peak aortic valve gradient at follow-up was lower than post-procedure (17.1 vs. 19.1 mm Hg; p = 0.002). More patients had none/trivial aortic regurgitation (AR) (47.5% vs. 33%), and fewer had mild AR (42.5% vs. 57%) at follow-up (p = 0.02). There was 1 case (0.4%) of severe SVD 5.3 years after implantation (new severe AR). There were 21 cases (8.7%) of moderate SVD (mean 6.1 years post-implantation; range 4.9 to 8.6 years). Twelve of these (57%) were due to new AR and 9 (43%) to restenosis. CONCLUSIONS: Long-term transcatheter aortic valve function is excellent. In the authors' study, 91% of patients remained free of SVD between 5 and 10 years post-implantation. The incidence of severe SVD was <1%. Moderate SVD occurred in 1 in 12 patients.
引用
- Blackman DJ, Saraf S, MacCarthy PA, et al. Long-Term Durability of Transcatheter Aortic Valve Prostheses. J Am Coll Cardiol. 2019. PMID: 30732706. doi:10.1016/j.jacc.2018.10.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。